All News
All News Stories
UofL cancer-targeting technology licensed to California medical company
January 10, 2019
California-based medical device company, Qualigen Inc., has licensed a drug technology developed at the University of Louisville that uses tiny, DNA-coated gold nanoparticles to target cancer.
McConnell Scholar: 'UofL one of the best things to happen to me'
January 9, 2019
Bridget Kim is a senior political science major and theatre arts minor from Morehead, Kentucky. She is also a McConnell Scholar.
Metabolite produced by gut microbiota from pomegranates reduces inflammatory bowel disease
January 9, 2019
Scientists at UofL have shown that a microbial metabolite, Urolithin A, derived from a compound found in berries and pomegranates, can reduce and protect against inflammatory bowel disease.